FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2122936729> ?p ?o ?g. }

• W2122936729 endingPage "753" @default.
• W2122936729 startingPage "740" @default.
• W2122936729 abstract "// Wen-Bin Yang 1 , Ping-Hsin Chen 2 , Tsung-I Hsu 3 , Tzu-Fun Fu 4 , Wu-Chou Su 5 , Hungjiun Liaw 6 , Wen-Chang Chang 7 and Jan-Jong Hung 1,2,3,7 , 1 Institute of Bioinformatics and Biosignal Transduction, College of Bioscience in Biotechnology, National Cheng Kung University, Tainan 701, Taiwan 2 Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan 3 Center for Infectious Disease and Signal Transduction Research, National Cheng Kung University, Tainan 701, Taiwan 4 Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan 5 Department of Internal Medicine, College of Medicine and Hospital, National Cheng Kung University, Tainan 701, Taiwan 6 Department of Life Sciences, College of Bioscience in Biotechnology, National Cheng Kung University, Tainan 701, Taiwan 7 Graduate Institute of Medical Sciences, College of Medicine, and Center for Neurotrauma and Neuroregeneration, Taipei Medical University, Taipei 110, Taiwan Correspondence: petehung, email: // Keywords : Sp1, miR-182, FOXO3, Lung cancer Received : November 18, 2013 Accepted : January 24, 2014 Published : January 25, 2014 Abstract Our recent study indicated that overexpression of Sp1 enhances the proliferation of lung cancer cells, while represses metastasis. In this study, we found that the transcriptional activity of FOXO3 was increased, but its protein levels decreased following Sp1 expression. Sp1 increased expression of miR-182, which was then recruited to the 3’-untranslated region of FOXO3 mRNA to silence its translational activity. Knockdown of miR-182 inhibited lung cancer cells growth, but enhanced the invasive and migratory abilities of these cells through increased N-cadherin expression. Repression of FOXO3 expression in the miR-182 knockdown cells partially reversed this effect, suggesting that miR-182 promotes cancer cell growth and inhibits cancer metastatic activity by regulating the expression of FOXO3. The expression of several cancer metastasis-related genes such as ADAM9, CDH9 and CD44 was increased following miR-182 knockdown. In conclusion, in the early stages of lung cancer progression, Sp1 stimulates miR-182 expression, which in turn decreases FOXO3 expression. This stimulates proliferation and tumor growth. In the late stages, Sp1 and miR-182 decline, thus increasing FOXO3 expression, which leads to lung metastasis." @default.
• W2122936729 created "2016-06-24" @default.
• W2122936729 creator A5005688184 @default.
• W2122936729 creator A5013291565 @default.
• W2122936729 creator A5033973207 @default.
• W2122936729 creator A5036098587 @default.
• W2122936729 creator A5045495656 @default.
• W2122936729 creator A5065378465 @default.
• W2122936729 creator A5067648304 @default.
• W2122936729 creator A5085247800 @default.
• W2122936729 date "2014-01-25" @default.
• W2122936729 modified "2023-10-16" @default.
• W2122936729 title "Sp1-mediated microRNA-182 expression regulates lung cancer progression" @default.
• W2122936729 cites W1510931988 @default.
• W2122936729 cites W1532263300 @default.
• W2122936729 cites W1561405118 @default.
• W2122936729 cites W1922521877 @default.
• W2122936729 cites W1963764316 @default.
• W2122936729 cites W1963961667 @default.
• W2122936729 cites W1970431885 @default.
• W2122936729 cites W1972456101 @default.
• W2122936729 cites W1976554071 @default.
• W2122936729 cites W1988156822 @default.
• W2122936729 cites W1990107313 @default.
• W2122936729 cites W1996118868 @default.
• W2122936729 cites W2000425266 @default.
• W2122936729 cites W2006797972 @default.
• W2122936729 cites W2011458493 @default.
• W2122936729 cites W2011925011 @default.
• W2122936729 cites W2012127976 @default.
• W2122936729 cites W2016700676 @default.
• W2122936729 cites W2019695782 @default.
• W2122936729 cites W2022013872 @default.
• W2122936729 cites W2034752670 @default.
• W2122936729 cites W2036378295 @default.
• W2122936729 cites W2037011799 @default.
• W2122936729 cites W2041921905 @default.
• W2122936729 cites W2051453787 @default.
• W2122936729 cites W2055026964 @default.
• W2122936729 cites W2055747658 @default.
• W2122936729 cites W2057929910 @default.
• W2122936729 cites W2062967876 @default.
• W2122936729 cites W2078899050 @default.
• W2122936729 cites W2087966784 @default.
• W2122936729 cites W2101801393 @default.
• W2122936729 cites W2102844520 @default.
• W2122936729 cites W2103946207 @default.
• W2122936729 cites W2106787323 @default.
• W2122936729 cites W2113915484 @default.
• W2122936729 cites W2127071805 @default.
• W2122936729 cites W2133098474 @default.
• W2122936729 cites W2133465414 @default.
• W2122936729 cites W2137031237 @default.
• W2122936729 cites W2137456063 @default.
• W2122936729 cites W2146604664 @default.
• W2122936729 cites W2148923243 @default.
• W2122936729 cites W2153479833 @default.
• W2122936729 cites W2154086676 @default.
• W2122936729 cites W2156645587 @default.
• W2122936729 cites W2158217645 @default.
• W2122936729 cites W2158341077 @default.
• W2122936729 cites W2162674813 @default.
• W2122936729 cites W2167226090 @default.
• W2122936729 cites W2168230240 @default.
• W2122936729 cites W2168552645 @default.
• W2122936729 doi "https://doi.org/10.18632/oncotarget.1608" @default.
• W2122936729 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3996653" @default.
• W2122936729 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24519909" @default.
• W2122936729 hasPublicationYear "2014" @default.
• W2122936729 type Work @default.
• W2122936729 sameAs 2122936729 @default.
• W2122936729 citedByCount "64" @default.
• W2122936729 countsByYear W21229367292014 @default.
• W2122936729 countsByYear W21229367292015 @default.
• W2122936729 countsByYear W21229367292016 @default.
• W2122936729 countsByYear W21229367292017 @default.
• W2122936729 countsByYear W21229367292018 @default.
• W2122936729 countsByYear W21229367292019 @default.
• W2122936729 countsByYear W21229367292020 @default.
• W2122936729 countsByYear W21229367292021 @default.
• W2122936729 countsByYear W21229367292022 @default.
• W2122936729 countsByYear W21229367292023 @default.
• W2122936729 crossrefType "journal-article" @default.
• W2122936729 hasAuthorship W2122936729A5005688184 @default.
• W2122936729 hasAuthorship W2122936729A5013291565 @default.
• W2122936729 hasAuthorship W2122936729A5033973207 @default.
• W2122936729 hasAuthorship W2122936729A5036098587 @default.
• W2122936729 hasAuthorship W2122936729A5045495656 @default.
• W2122936729 hasAuthorship W2122936729A5065378465 @default.
• W2122936729 hasAuthorship W2122936729A5067648304 @default.
• W2122936729 hasAuthorship W2122936729A5085247800 @default.
• W2122936729 hasBestOaLocation W21229367291 @default.
• W2122936729 hasConcept C104317684 @default.
• W2122936729 hasConcept C126322002 @default.
• W2122936729 hasConcept C143998085 @default.
• W2122936729 hasConcept C145059251 @default.
• W2122936729 hasConcept C173396325 @default.
• W2122936729 hasConcept C190283241 @default.

• next